Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

APOE Antikörper

APOE Reaktivität: Human WB, IP, IHC (p), IHC (fro), EIA Wirt: Ziege Polyclonal unconjugated
Produktnummer ABIN116547
  • Target Alle APOE Antikörper anzeigen
    APOE (Apolipoprotein E (APOE))
    Reaktivität
    • 101
    • 75
    • 56
    • 2
    • 2
    • 2
    • 1
    • 1
    Human
    Wirt
    • 101
    • 22
    • 14
    • 2
    Ziege
    Klonalität
    • 105
    • 33
    Polyklonal
    Konjugat
    • 58
    • 18
    • 12
    • 7
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    Dieser APOE Antikörper ist unkonjugiert
    Applikation
    • 110
    • 58
    • 39
    • 39
    • 30
    • 24
    • 19
    • 12
    • 9
    • 8
    • 6
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunoprecipitation (IP), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Enzyme Immunoassay (EIA)
    Spezifität
    This product has been prepared by Immunoaffinity chromatography using immobilized antigens followed by extensive cross-adsorption against other Apolipoproteins and human serum proteins to remove any unwanted specificities. Typically less than 1 % cross reactivity against other types of apoLipoprotein was detected by ELISA against purified standards. This antibody reacts with human Apolipoprotein E and has negligible cross-reactivity with Type A-1 A-II, B, C-I, C-II, C-III and J Apolipoproteins. Specific cross reaction of anti-Apolipoprotein antibodies with antigens from other species has not been determined. Non-specific cross reaction of anti-Apolipoprotein antibodies with other human serum proteins is negligible.
    Aufreinigung
    Immunoaffinity Chromatography
    Immunogen
    Apolipoprotein Type E was isolated from Human plasma by density gradient centrifugation followed by HPLC purification.
    Top Product
    Discover our top product APOE Primärantikörper
  • Applikationshinweise
    Anti-apoLipoprotein antibodies have been used for indirect trapping ELISA for quantitationof antigen in serum using a standard curve, for immunoprecipitation and for westernblotting for highly sensitive qualitative analysis. Recommended dilutions: ELISA: 1/4,000-1/8,000Western blot: 1/500-1/2,000Immunohistochemistry: 1/50-1/200
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1.0 mg/mL (by UV absorbance at 280 nm)
    Buffer
    0.125 M Sodium Borate, 0.075 M Sodium Chloride, 0.005 M EDTA, pH 8.0, containing 0.01 % Sodium Azide as preservtive
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Avoid repeated freezing and thawing.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store the antibody undiluted at 2-8 °C for one month or (in aliquts) at -20 °C for longer.
  • Target
    APOE (Apolipoprotein E (APOE))
    Andere Bezeichnung
    Apolipoprotein E (Apo E) (APOE Produkte)
    Synonyme
    ad2 antikoerper, apoprotein antikoerper, im:7036787 antikoerper, wu:fb69a05 antikoerper, zgc:110064 antikoerper, apoe antikoerper, AI255918 antikoerper, AD2 antikoerper, LDLCQ5 antikoerper, LPG antikoerper, APOEA antikoerper, Apo-E antikoerper, apolipoprotein E antikoerper, apolipoprotein Ea antikoerper, apoe antikoerper, apoea antikoerper, Apoe antikoerper, APOE antikoerper
    Hintergrund
    Apolipoprotein E is essential for the normal catabolism of triglyceride rich lipoprotein constituents. The apolipoprotein E gene is mapped to chromosome 19 in a cluster with APOC1 and APOC2. Defects in Apolipoprotein E result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants. Mutations in the APOE gene confer susceptibility to Alzheimer's disease by affecting amyloid-beta deposition.Synonyms: Apo-E, ApoE
    Gen-ID
    348
    NCBI Accession
    NP_000032
    UniProt
    P02649
    Pathways
    Regulation of Cell Size, Lipid Metabolism
Sie sind hier:
Blank Blank Blank Blank
Blank Blank Blank Blank
Kundenservice